1. Home
  2. TMCI vs GNE Comparison

TMCI vs GNE Comparison

Compare TMCI & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • GNE
  • Stock Information
  • Founded
  • TMCI 2014
  • GNE 2011
  • Country
  • TMCI United States
  • GNE United States
  • Employees
  • TMCI N/A
  • GNE N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GNE Power Generation
  • Sector
  • TMCI Health Care
  • GNE Utilities
  • Exchange
  • TMCI Nasdaq
  • GNE Nasdaq
  • Market Cap
  • TMCI 401.8M
  • GNE 419.3M
  • IPO Year
  • TMCI 2021
  • GNE N/A
  • Fundamental
  • Price
  • TMCI $6.03
  • GNE $15.56
  • Analyst Decision
  • TMCI Hold
  • GNE
  • Analyst Count
  • TMCI 5
  • GNE 0
  • Target Price
  • TMCI $8.60
  • GNE N/A
  • AVG Volume (30 Days)
  • TMCI 292.8K
  • GNE 159.9K
  • Earning Date
  • TMCI 11-04-2025
  • GNE 11-05-2025
  • Dividend Yield
  • TMCI N/A
  • GNE 1.94%
  • EPS Growth
  • TMCI N/A
  • GNE 4.51
  • EPS
  • TMCI N/A
  • GNE 0.31
  • Revenue
  • TMCI $213,751,000.00
  • GNE $456,876,000.00
  • Revenue This Year
  • TMCI $10.63
  • GNE $14.60
  • Revenue Next Year
  • TMCI $9.43
  • GNE $8.64
  • P/E Ratio
  • TMCI N/A
  • GNE $50.44
  • Revenue Growth
  • TMCI 7.67
  • GNE 3.75
  • 52 Week Low
  • TMCI $4.54
  • GNE $13.05
  • 52 Week High
  • TMCI $10.79
  • GNE $28.47
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 29.93
  • GNE 49.41
  • Support Level
  • TMCI $6.09
  • GNE $14.70
  • Resistance Level
  • TMCI $6.52
  • GNE $15.28
  • Average True Range (ATR)
  • TMCI 0.31
  • GNE 0.52
  • MACD
  • TMCI -0.11
  • GNE 0.18
  • Stochastic Oscillator
  • TMCI 0.00
  • GNE 57.88

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

Share on Social Networks: